Selected research
Industry Growth & Trends
Global Bispecific Antibody Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Bispecific Antibody Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Bispecific Antibody Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Bispecific Antibody Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bispecific Antibody Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Bispecific Antibody Drug market include Affimed, Akeso, Alphamab, BeiGene, Genmab, Immunocore Limited, Lindis Biotech, MacroGenics and Xencor, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Bispecific Antibody Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bispecific Antibody Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bispecific Antibody Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bispecific Antibody Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Bispecific Antibody Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bispecific Antibody Drug Market by Company
Affimed
Akeso
Alphamab
BeiGene
Genmab
Immunocore Limited
Lindis Biotech
MacroGenics
Xencor
AstraZeneca
Abbvie
Amgen
Pfizer
Roche
Merck
Johnson & Johnson
Sanofi
Bispecific Antibody Drug Segment by Type
Fragment-Based
IgG-Based
Bispecific Antibody Drug Segment by Application
Cancer
Haemophilia
Other Diseases
Bispecific Antibody Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bispecific Antibody Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bispecific Antibody Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bispecific Antibody Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Bispecific Antibody Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fragment-Based
- IgG-Based
Applications
- Cancer
- Haemophilia
- Other Diseases
Companies covered
- Affimed
- Akeso
- Alphamab
- BeiGene
- Genmab
- Immunocore Limited
- Lindis Biotech
- MacroGenics
- Xencor
- AstraZeneca
- Abbvie
- Amgen
- Pfizer
- Roche
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Bispecific Antibody Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Bispecific Antibody Drug Market Size by Region (2021-2032)
- 1.4.1 Global Bispecific Antibody Drug Market Size by Region (2021-2026)
- 1.4.2 Global Bispecific Antibody Drug Market Size by Region (2027-2032)
- 1.5 Key Regions Bispecific Antibody Drug Market Size (2021-2032)
- 1.5.1 North America Bispecific Antibody Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Bispecific Antibody Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Bispecific Antibody Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America Bispecific Antibody Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Bispecific Antibody Drug Market Size Growth Rate (2021-2032)
2 Bispecific Antibody Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Fragment-Based
- 2.1.2 IgG-Based
- 2.2 Global Bispecific Antibody Drug Market Size by Type
- 2.2.1 Global Bispecific Antibody Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global Bispecific Antibody Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Bispecific Antibody Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global Bispecific Antibody Drug Market Size by Regions
- 2.3.1 North America Bispecific Antibody Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Bispecific Antibody Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Bispecific Antibody Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Bispecific Antibody Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Bispecific Antibody Drug Market Size Breakdown by Type (2021-2026)
3 Bispecific Antibody Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 Haemophilia
- 3.1.3 Other Diseases
- 3.2 Global Bispecific Antibody Drug Market Size by Application
- 3.2.1 Global Bispecific Antibody Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global Bispecific Antibody Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Bispecific Antibody Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global Bispecific Antibody Drug Market Size by Regions
- 3.3.1 North America Bispecific Antibody Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Bispecific Antibody Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Bispecific Antibody Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Bispecific Antibody Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Bispecific Antibody Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Bispecific Antibody Drug Industry Trends
- 4.2 Bispecific Antibody Drug Industry Drivers
- 4.3 Bispecific Antibody Drug Industry Opportunities and Challenges
- 4.4 Bispecific Antibody Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Bispecific Antibody Drug Revenue (2021-2026)
- 5.2 Global Bispecific Antibody Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Bispecific Antibody Drug Key Company Headquarters & Area Served
- 5.4 Global Bispecific Antibody Drug Company, Product Type & Application
- 5.5 Global Bispecific Antibody Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Bispecific Antibody Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Bispecific Antibody Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 Bispecific Antibody Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Affimed
- 6.1.1 Affimed Company Information
- 6.1.2 Affimed Business Overview
- 6.1.3 Affimed Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Affimed Bispecific Antibody Drug Product Portfolio
- 6.1.5 Affimed Recent Developments
- 6.2 Akeso
- 6.2.1 Akeso Company Information
- 6.2.2 Akeso Business Overview
- 6.2.3 Akeso Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Akeso Bispecific Antibody Drug Product Portfolio
- 6.2.5 Akeso Recent Developments
- 6.3 Alphamab
- 6.3.1 Alphamab Company Information
- 6.3.2 Alphamab Business Overview
- 6.3.3 Alphamab Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Alphamab Bispecific Antibody Drug Product Portfolio
- 6.3.5 Alphamab Recent Developments
- 6.4 BeiGene
- 6.4.1 BeiGene Company Information
- 6.4.2 BeiGene Business Overview
- 6.4.3 BeiGene Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 BeiGene Bispecific Antibody Drug Product Portfolio
- 6.4.5 BeiGene Recent Developments
- 6.5 Genmab
- 6.5.1 Genmab Company Information
- 6.5.2 Genmab Business Overview
- 6.5.3 Genmab Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Genmab Bispecific Antibody Drug Product Portfolio
- 6.5.5 Genmab Recent Developments
- 6.6 Immunocore Limited
- 6.6.1 Immunocore Limited Company Information
- 6.6.2 Immunocore Limited Business Overview
- 6.6.3 Immunocore Limited Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Immunocore Limited Bispecific Antibody Drug Product Portfolio
- 6.6.5 Immunocore Limited Recent Developments
- 6.7 Lindis Biotech
- 6.7.1 Lindis Biotech Company Information
- 6.7.2 Lindis Biotech Business Overview
- 6.7.3 Lindis Biotech Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Lindis Biotech Bispecific Antibody Drug Product Portfolio
- 6.7.5 Lindis Biotech Recent Developments
- 6.8 MacroGenics
- 6.8.1 MacroGenics Company Information
- 6.8.2 MacroGenics Business Overview
- 6.8.3 MacroGenics Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 MacroGenics Bispecific Antibody Drug Product Portfolio
- 6.8.5 MacroGenics Recent Developments
- 6.9 Xencor
- 6.9.1 Xencor Company Information
- 6.9.2 Xencor Business Overview
- 6.9.3 Xencor Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Xencor Bispecific Antibody Drug Product Portfolio
- 6.9.5 Xencor Recent Developments
- 6.10 AstraZeneca
- 6.10.1 AstraZeneca Company Information
- 6.10.2 AstraZeneca Business Overview
- 6.10.3 AstraZeneca Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AstraZeneca Bispecific Antibody Drug Product Portfolio
- 6.10.5 AstraZeneca Recent Developments
- 6.11 Abbvie
- 6.11.1 Abbvie Company Information
- 6.11.2 Abbvie Business Overview
- 6.11.3 Abbvie Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Abbvie Bispecific Antibody Drug Product Portfolio
- 6.11.5 Abbvie Recent Developments
- 6.12 Amgen
- 6.12.1 Amgen Company Information
- 6.12.2 Amgen Business Overview
- 6.12.3 Amgen Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Amgen Bispecific Antibody Drug Product Portfolio
- 6.12.5 Amgen Recent Developments
- 6.13 Pfizer
- 6.13.1 Pfizer Company Information
- 6.13.2 Pfizer Business Overview
- 6.13.3 Pfizer Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Pfizer Bispecific Antibody Drug Product Portfolio
- 6.13.5 Pfizer Recent Developments
- 6.14 Roche
- 6.14.1 Roche Company Information
- 6.14.2 Roche Business Overview
- 6.14.3 Roche Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Roche Bispecific Antibody Drug Product Portfolio
- 6.14.5 Roche Recent Developments
- 6.15 Merck
- 6.15.1 Merck Company Information
- 6.15.2 Merck Business Overview
- 6.15.3 Merck Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Merck Bispecific Antibody Drug Product Portfolio
- 6.15.5 Merck Recent Developments
- 6.16 Johnson & Johnson
- 6.16.1 Johnson & Johnson Company Information
- 6.16.2 Johnson & Johnson Business Overview
- 6.16.3 Johnson & Johnson Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Johnson & Johnson Bispecific Antibody Drug Product Portfolio
- 6.16.5 Johnson & Johnson Recent Developments
- 6.17 Sanofi
- 6.17.1 Sanofi Company Information
- 6.17.2 Sanofi Business Overview
- 6.17.3 Sanofi Bispecific Antibody Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Sanofi Bispecific Antibody Drug Product Portfolio
- 6.17.5 Sanofi Recent Developments
7 North America
- 7.1 North America Bispecific Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Bispecific Antibody Drug Market Size by Country (2021-2026)
- 7.3 North America Bispecific Antibody Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Bispecific Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Bispecific Antibody Drug Market Size by Country (2021-2026)
- 8.3 Europe Bispecific Antibody Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Bispecific Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Bispecific Antibody Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Bispecific Antibody Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Bispecific Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Bispecific Antibody Drug Market Size by Country (2021-2026)
- 10.3 South America Bispecific Antibody Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Bispecific Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Bispecific Antibody Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst